Microbiome‐Skin‐Brain Axis: A Novel Paradigm for Cutaneous Wounds

Microbiome‐Skin‐Brain Axis: A Novel Paradigm for Cutaneous Wounds:

ABSTRACT

Chronic wounds cause a significant burden on society financially, medically, and psychologically. Unfortunately, patients with non‐healing wounds often suffer from comorbidities that further compound their disability. Given the high rate of depressive symptoms experienced by patients with chronic wounds, further studies are needed to investigate the potentially linked pathophysiological changes in wounds and depression in order to improve patient care.

The English literature on wound healing, inflammatory and microbial changes in chronic wounds and depression, and anti‐inflammatory and probiotic therapy was reviewed on PubMed.

Chronic wound conditions and depression were demonstrated to share common pathologic features of dysregulated inflammation and altered microbiome, indicating a possible relationship. Furthermore, alternative treatment strategies such as immune‐targeted and probiotic therapy showed promising potential by addressing both pathophysiological pathways. However, many existing studies are limited to a small study population, a cross‐sectional design that does not establish temporality, or a wide range of confounding variables in the context of a highly complex and multifactorial disease process. Therefore, additional pre‐clinical studies in suitable wound models, as well as larger clinical cohort studies and trials are necessary to elucidate the relationship between wound microbiome, healing, and depression, and ultimately guide the most effective therapeutic and management plan for chronic wound patients.

This article is protected by copyright. All rights reserved.